Games developer tinyBuild seeks to boost £500 million market cap by becoming a media company. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8,383.00
Bid: 8,380.00
Ask: 8,382.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.02%)
Open: 8,316.00
High: 8,383.00
Low: 8,279.00
Yest. Close: 8,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UPDATE 1-German panel to recommend J&J COVID vaccine for over-60s - Spiegel

Fri, 7th May 2021 12:24

(Adds RKI comment, background)

BERLIN, May 7 (Reuters) - Germany's vaccine committee, known
as STIKO, plans to recommend Johnson & Johnson's
COVID-19 vaccine only for people over the age of 60, German
magazine Der Spiegel reported on Friday, citing no sources.

Europe's drug regulator approved J&J's vaccine last month
after examining cases of a rare blood clotting issue in U.S.
adults who received a dose. But it left it up to the European
Union's member states to decide how to use it.

A spokeswoman for the Robert Koch Institute (RKI) for
infectious diseases said the institute expects STIKO to make a
recommendation on J&J's vaccine next week. She declined to
comment further.

Germany limited the shot from Anglo-Swedish drugmaker
AstraZeneca to people over 60 after post-vaccination
monitoring found rare - and sometimes fatal - cases of blood
clotting, with younger women disproportionately affected.

Health Minister Jens Spahn announced on Thursday that
Germany would make AstraZeneca available to all adults,
regardless of age, to speed up its vaccination campaign.

The decision by the federal government follows moves by
several German states to make AstraZeneca more widely available
and comes as the pace of giving shots of mainstay vaccines from
BioNTech/Pfizer and Moderna picks up.

(Reporting by Maria Sheahan
Editing by Riham Alkousaa and Thomas Escritt)

More News

England invites all adults to get their COVID-19 vaccines

LONDON, June 17 (Reuters) - The health service in England will open up COVID-19 vaccinations to everyone aged over 18 on Friday, a big step towards the government's target of giving every adult who wants a vaccine a first shot in the next month.Pr...

17 Jun 21 22:30

IN BRIEF: DeepMatter partners with universities on automated precision

IN BRIEF: DeepMatter partners with universities on automated precision

17 Jun 21 19:14

EU drug regulator records 415 cases of possible rare blood clotting

LONDON, June 17 (Reuters) - The EU drug regulator said on Thursday it has received reports of 415 possible cases of rare blood clotting with a low platelet count in the European Economic Area, out of more than 50 million people who have received ...

17 Jun 21 15:27

Redx Pharma gets milestone sum from AstraZeneca for therapy progress

Redx Pharma gets milestone sum from AstraZeneca for therapy progress

17 Jun 21 14:07

Thursday broker round-up

(Sharecast News) - Pets At Home: Liberum upgrades to buy with a target price of 510p.

17 Jun 21 13:49

UPDATE 2-Denmark to immunize 12-15 year-olds against COVID-19 ahead of winter

(Adds details on immunity)By Nikolaj SkydsgaardCOPENHAGEN, June 17 (Reuters) - Denmark will offer COVID-19 vaccines for children aged 12-15 after the adult population has been inoculated to boost its overall immunity against the virus ahead of the...

17 Jun 21 11:32

Denmark to administer COVID-19 vaccines for children aged 12-15 - TV 2

COPENHAGEN, June 17 (Reuters) - Denmark will administer COVID-19 vaccines for children aged 12-15, broadcaster TV 2 reported on Thursday, citing sources.Danish health authorities are due to hold a news briefing to about using the vaccines on that ...

17 Jun 21 10:49

IP Group investee Apollo Therapeutics completes USD145 million raise

IP Group investee Apollo Therapeutics completes USD145 million raise

17 Jun 21 09:48

BROKER RATINGS: Bank of America double upgrades Morrisons to Buy

BROKER RATINGS: Bank of America double upgrades Morrisons to Buy

17 Jun 21 09:36

Australia further restricts AstraZeneca vaccine over clotting concerns

Australia further restricts AstraZeneca vaccine over clotting concerns

17 Jun 21 06:19

JPMorgan, Goldman Sachs delay workers' return to U.K. offices

By Elizabeth Dilts MarshallNEW YORK, June 16 (Reuters) - Global banks JPMorgan Chase & Co and Goldman Sachs are delaying plans for workers to return to U.K. offices after the government extended its COVID-19 restrictions until mid-July due to the ...

16 Jun 21 21:39

COVID SCIENCE-Regeneron antibodies help asymptomatic and hospitalized patients; some lymph node cancers limit vaccine response

By Nancy LapidJune 16 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.Regeneron COVID-19 drug helps ...

16 Jun 21 20:26

Wednesday broker round-up

(Sharecast News) - Pets At Home: Berenberg reiterates buy with a target price of 540p.

16 Jun 21 12:50

UPDATE 1-Regeneron's antibody therapy cuts deaths among some hospitalised COVID-19 patients -study

* Therapy cut deaths by one-fifth in the seronegative* Can be used in combination with other treatments* Finding bodes well for other antibody treatments (Adds quote, comments on cost effectiveness)By Alistair SmoutLONDON, June 16 (Reuters) - A COVI...

16 Jun 21 12:02

Regeneron COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies -study

* Antibody cocktail cut deaths by one-fifth in the seronegative* Therapy can be used in combination with other treatments* Finding bodes well for other monoclonal antibody treatmentsBy Alistair SmoutLONDON, June 16 (Reuters) - Regeneron Pharmaceuti...

16 Jun 21 06:00

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.